Šalis: Didžioji Britanija
kalba: anglų
Šaltinis: MHRA (Medicines & Healthcare Products Regulatory Agency)
Tolnaftate
SSL International Plc
D01AE18
Tolnaftate
10mg/1gram
Cutaneous powder
Cutaneous
No Controlled Drug Status
Valid as a prescribable product
BNF: 13100200; GTIN: 5000288454118
OBJECT 1 SCHOLL ATHLETE'S FOOT POWDER Summary of Product Characteristics Updated 05-Oct-2016 | SSL International plc 1. Name of the medicinal product Scholl Athletes Foot Powder Superdrug Athletes Foot Powder 2. Qualitative and quantitative composition Tolnaftate 1.0%w/w For the full list of excipients, see section 6.1. 3. Pharmaceutical form Powder for topical application 4. Clinical particulars 4.1 Therapeutic indications For the prevention and treatment of Athlete's Foot. 4.2 Posology and method of administration Wash and dry infected area, and apply twice daily or as directed by your doctor. Dust feet liberally, especially between toes. For added protection dust on socks, hosiery and inside shoes. Continue treatment for two weeks after symptoms disappear. 4.3 Contraindications Not recommended for nail or scalp infections. Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. 4.4 Special warnings and precautions for use For external use only Keep out of eyes If symptoms do not improve within 10 days, discontinue use and consult your doctor Keep out of the reach and sight of children 4.5 Interaction with other medicinal products and other forms of interaction Not relevant to topical use 4.6 Pregnancy and lactation No known restrictions. 4.7 Effects on ability to drive and use machines None stated. 4.8 Undesirable effects Adverse reactions have been ranked under headings of frequency using the following convention: Very common ≥ 1/10 Common ≥ 1/100 to ≥ 1/10 Uncommon ≥ 1/1,000 to < 1/100 Rare ≥ 1/10,000 to < 1/1,000 Very rare <1/10,000 Within easy frequency grouping, undesirable effects are presented in order of decreasing seriousness. System Organ Class Frequency Skin and subcutaneous tissue disorder Unknown Skin reactions Skin irritation Pruritis Contact dermatitis 4.9 Overdose Not relevant to topical use. 5. Pharmacological properties 5.1 Pharmacodynamic properties Tolnaftate Topical antifungal agent (ATC Classification: D01AE 18) 5.2 Pharmacokinetic properties Perskaitykite visą dokumentą